A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive Disorder
Clinical trial NCT03352453 · TERMINATED
Trial details
- NCT number
- NCT03352453
- Sponsor
- Naurex, Inc, an affiliate of Allergan plc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-15
- Primary completion
- 2019-06-21
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.